Long-term use of neuromuscular blockers associated with increased 90-day mortality in mechanically ventilated patients in the ICU: a retrospective cohort study

Objective To analyze the safety and efficacy of neuromuscular blockers (NMBAs) in mechanically ventilated patients in the ICU. Methods A retrospective analysis was conducted on data from adult patients admitted to the ICU of Deyang People's Hospital and received mechanical ventilation from 20...

Full description

Saved in:
Bibliographic Details
Main Author: LIAO Jian*, LU Dingyu, WU Zhixuan, ZHANG Lian, XIE Hong, WANG Maojuan
Format: Article
Language:zho
Published: The Editorial Department of Chinese Journal of Clinical Research 2025-04-01
Series:Zhongguo linchuang yanjiu
Subjects:
Online Access:http://zglcyj.ijournals.cn/zglcyj/ch/reader/create_pdf.aspx?file_no=20250419
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850156381896704000
author LIAO Jian*, LU Dingyu, WU Zhixuan, ZHANG Lian, XIE Hong, WANG Maojuan
author_facet LIAO Jian*, LU Dingyu, WU Zhixuan, ZHANG Lian, XIE Hong, WANG Maojuan
author_sort LIAO Jian*, LU Dingyu, WU Zhixuan, ZHANG Lian, XIE Hong, WANG Maojuan
collection DOAJ
description Objective To analyze the safety and efficacy of neuromuscular blockers (NMBAs) in mechanically ventilated patients in the ICU. Methods A retrospective analysis was conducted on data from adult patients admitted to the ICU of Deyang People's Hospital and received mechanical ventilation from 2015 to 2022. Demographic characteristics, laboratory data, mechanical ventilation parameters [positive end-expiratory pressure (PEEP), mean airway pressure (Pmean), peak airway pressure (Ppeak)], arterial blood gas data [pH, arterial oxygen partial pressure (PaO2), arterial carbon dioxide partial pressure (PaCO2)], NMBA usage, length of ICU stay, and 90-day mortality were collected and analyzed. Results A total of 2 765 mechanically ventilated patients were included, of which 55.23% were male, aged (69.89±14.66) years, and the 90-day mortality rate during ICU stay was 30.78% (851/2765). Compared to the survivors, the mortality group had an older age, lower BMI, as well as higher sequential organ failure assessment (SOFA) score, acute physiological score (APS), systemic inflammatory response syndrome (SIRS) score, simplified acute physiology score Ⅱ (SAPS Ⅱ) score and Oxford acute severity of illness score (OASIS) (P<0.05). In the mortality group, the duration of mechanical ventilation was longer [137 (90, 237)h vs 75 (36, 143)h, Z=15.22, P<0.05], and the length of ICU stay was longer [7 (5, 12)d vs 5 (3, 10)d, Z=11.39, P<0.05], and were also more likely to receive NMBA treatment for more than 48 hours (4.23% vs 1.67%, P<0.05) compared to the survival group. After adjusting for age, sex, and relevant covariates, the use of NMBAs for more than 48 hours was found to be independently associated with increased mortality risk (adjusted HR=2.48, 95%CI: 1.75-3.50). Subgroup analysis showed that this association was stronger in patients requiring higher PEEP (HR=2.90, 95%CI: 1.72-4.88). Conclusion Long-term use of NMBA is associated with an increased long-term mortality risk in critically ill patients requiring mechanical ventilation. Further research is needed to validate these findings.
format Article
id doaj-art-5fa0834bc80344c994e81870c635d8be
institution OA Journals
issn 1674-8182
language zho
publishDate 2025-04-01
publisher The Editorial Department of Chinese Journal of Clinical Research
record_format Article
series Zhongguo linchuang yanjiu
spelling doaj-art-5fa0834bc80344c994e81870c635d8be2025-08-20T02:24:34ZzhoThe Editorial Department of Chinese Journal of Clinical ResearchZhongguo linchuang yanjiu1674-81822025-04-0138458258710.13429/j.cnki.cjcr.2025.04.019Long-term use of neuromuscular blockers associated with increased 90-day mortality in mechanically ventilated patients in the ICU: a retrospective cohort studyLIAO Jian*, LU Dingyu, WU Zhixuan, ZHANG Lian, XIE Hong, WANG Maojuan 0*Department of Critical Care Medicine, Deyang People's Hospital, Deyang, Sichuan 618000, ChinaObjective To analyze the safety and efficacy of neuromuscular blockers (NMBAs) in mechanically ventilated patients in the ICU. Methods A retrospective analysis was conducted on data from adult patients admitted to the ICU of Deyang People's Hospital and received mechanical ventilation from 2015 to 2022. Demographic characteristics, laboratory data, mechanical ventilation parameters [positive end-expiratory pressure (PEEP), mean airway pressure (Pmean), peak airway pressure (Ppeak)], arterial blood gas data [pH, arterial oxygen partial pressure (PaO2), arterial carbon dioxide partial pressure (PaCO2)], NMBA usage, length of ICU stay, and 90-day mortality were collected and analyzed. Results A total of 2 765 mechanically ventilated patients were included, of which 55.23% were male, aged (69.89±14.66) years, and the 90-day mortality rate during ICU stay was 30.78% (851/2765). Compared to the survivors, the mortality group had an older age, lower BMI, as well as higher sequential organ failure assessment (SOFA) score, acute physiological score (APS), systemic inflammatory response syndrome (SIRS) score, simplified acute physiology score Ⅱ (SAPS Ⅱ) score and Oxford acute severity of illness score (OASIS) (P<0.05). In the mortality group, the duration of mechanical ventilation was longer [137 (90, 237)h vs 75 (36, 143)h, Z=15.22, P<0.05], and the length of ICU stay was longer [7 (5, 12)d vs 5 (3, 10)d, Z=11.39, P<0.05], and were also more likely to receive NMBA treatment for more than 48 hours (4.23% vs 1.67%, P<0.05) compared to the survival group. After adjusting for age, sex, and relevant covariates, the use of NMBAs for more than 48 hours was found to be independently associated with increased mortality risk (adjusted HR=2.48, 95%CI: 1.75-3.50). Subgroup analysis showed that this association was stronger in patients requiring higher PEEP (HR=2.90, 95%CI: 1.72-4.88). Conclusion Long-term use of NMBA is associated with an increased long-term mortality risk in critically ill patients requiring mechanical ventilation. Further research is needed to validate these findings. http://zglcyj.ijournals.cn/zglcyj/ch/reader/create_pdf.aspx?file_no=20250419neuromuscular blockersmechanical ventilationmortality risk
spellingShingle LIAO Jian*, LU Dingyu, WU Zhixuan, ZHANG Lian, XIE Hong, WANG Maojuan
Long-term use of neuromuscular blockers associated with increased 90-day mortality in mechanically ventilated patients in the ICU: a retrospective cohort study
Zhongguo linchuang yanjiu
neuromuscular blockers
mechanical ventilation
mortality risk
title Long-term use of neuromuscular blockers associated with increased 90-day mortality in mechanically ventilated patients in the ICU: a retrospective cohort study
title_full Long-term use of neuromuscular blockers associated with increased 90-day mortality in mechanically ventilated patients in the ICU: a retrospective cohort study
title_fullStr Long-term use of neuromuscular blockers associated with increased 90-day mortality in mechanically ventilated patients in the ICU: a retrospective cohort study
title_full_unstemmed Long-term use of neuromuscular blockers associated with increased 90-day mortality in mechanically ventilated patients in the ICU: a retrospective cohort study
title_short Long-term use of neuromuscular blockers associated with increased 90-day mortality in mechanically ventilated patients in the ICU: a retrospective cohort study
title_sort long term use of neuromuscular blockers associated with increased 90 day mortality in mechanically ventilated patients in the icu a retrospective cohort study
topic neuromuscular blockers
mechanical ventilation
mortality risk
url http://zglcyj.ijournals.cn/zglcyj/ch/reader/create_pdf.aspx?file_no=20250419
work_keys_str_mv AT liaojianludingyuwuzhixuanzhanglianxiehongwangmaojuan longtermuseofneuromuscularblockersassociatedwithincreased90daymortalityinmechanicallyventilatedpatientsintheicuaretrospectivecohortstudy